Your browser doesn't support javascript.
loading
Perspectives on future Alzheimer therapies: amyloid-ß protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer's disease.
Lannfelt, Lars; Möller, Christer; Basun, Hans; Osswald, Gunilla; Sehlin, Dag; Satlin, Andrew; Logovinsky, Veronika; Gellerfors, Pär.
Affiliation
  • Lannfelt L; Department of Public Health/Geriatrics, Uppsala University, Dag Hammarskölds väg 14 B, 751 85 Uppsala, Sweden ; BioArctic Neuroscience AB, Warfvinges väg 35, 112 51 Stockholm, Sweden.
  • Möller C; BioArctic Neuroscience AB, Warfvinges väg 35, 112 51 Stockholm, Sweden.
  • Basun H; Department of Public Health/Geriatrics, Uppsala University, Dag Hammarskölds väg 14 B, 751 85 Uppsala, Sweden ; BioArctic Neuroscience AB, Warfvinges väg 35, 112 51 Stockholm, Sweden.
  • Osswald G; BioArctic Neuroscience AB, Warfvinges väg 35, 112 51 Stockholm, Sweden.
  • Sehlin D; Department of Public Health/Geriatrics, Uppsala University, Dag Hammarskölds väg 14 B, 751 85 Uppsala, Sweden.
  • Satlin A; Eisai, Inc, 100 Tice Boulevard, Woodcliff Lake, NJ 07677, USA.
  • Logovinsky V; Eisai, Inc, 100 Tice Boulevard, Woodcliff Lake, NJ 07677, USA.
  • Gellerfors P; BioArctic Neuroscience AB, Warfvinges väg 35, 112 51 Stockholm, Sweden.
Alzheimers Res Ther ; 6(2): 16, 2014.
Article in En | MEDLINE | ID: mdl-25031633

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Language: En Journal: Alzheimers Res Ther Year: 2014 Document type: Article Affiliation country: Suecia

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Language: En Journal: Alzheimers Res Ther Year: 2014 Document type: Article Affiliation country: Suecia